AwardedUnited KingdomGoods£4,074,117
Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity
- Published
- Published 12 March 2026
- Deadline
- Closed 12 March 2026
Overview
EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE for Spinal Muscular Atrophy (SMA).
Key details
- Country
- United Kingdom
- Status
- Awarded
- Category
- Goods
- Estimated value
- £4,074,117
- Procedure
- Selective
- SME suitable
- Yes
- Published
- 12 March 2026
- Deadline
- Closed
Medical equipments
Award outcome
- Awarded value
- £4,074,117
- Award date
- 25 March 2026
- Contract period
- 31 March 2026 → 31 March 2029
- Revvity (UK) Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
12 March 2026
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.